News | News By Subject | News by Disease News By Date | Search News

Parkinson's disease News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Acorda (ACOR) Rockets After Parkinson's Drug Hits Late-Stage Goals     2/10/2017
Merck KGaA (MKGAF.PK) Spinout Prexton Nabs $31 Million to Fund Phase II Parkinson's Trials     2/7/2017
Key Parkinson's Trial Delayed Due to Feud Between a Georgetown University Scientist and The Michael J. Fox Foundation     8/31/2016
Acadia (ACAD) Drug Approval May Make It an Attractive Target for Biogen (BIIB), Teva (TEVA)     5/9/2016
FDA Clears Acadia (ACAD)'s NUPLAZID, the First Drug for Psychosis Linked to Parkinson's     5/2/2016
Acorda (ACOR)'s Parkinson’s Candidate Meets Goal in Phase II Trial     4/20/2016
Acadia (ACAD) Surges as FDA Panel Backs Psychosis Drug Linked to Parkinson’s Disease     3/30/2016
FDA Staff Says Acadia (ACAD)'s Drug for Parkinson's Disease Psychosis Nuplazid is Effective     3/28/2016
Three Biotechs Cited as Promising Bets in 2016 With FDA Decisions Pending     2/22/2016
Acorda (ACOR) Bulks Up Parkinson's Pipeline with $363 Million Takeover of Biotie     1/20/2016
Adamas Pharmaceuticals (ADMS)' Lead Drug ADS-5102 Meets Phase III Goals; Stock Surges     12/28/2015
Novartis AG (NVS) Cancer Drug May Help Parkinson's Patients     10/19/2015
Exciting Time for Biotech in New Jersey     6/29/2015
Pfizer (PFE) Agrees to Pay Off Parkinson Patients Who Developed Gambling and Sex Addiction While On Cabaser     5/11/2015
FDA Lifts Clinical Hold on NeuroDerm (NDRM)'s Lead Parkinson's Candidates     5/11/2015

News from Around the Web
To Probe Parkinson’s, Treat The Brain Like A Piece Of Electronics, Stanford University Study     1/30/2017
Parkinson's Linked To Gut Bacteria, California Institute of Technology Study     12/2/2016
How This Small Wearable Could Help Doctors Spot Parkinson's Earlier, University Politehnica Of Bucharest Study     9/16/2016
DNA Brain Injection Could Help Control Parkinson's Symptoms, Voyager Therapeutics (VYGR) Reveals     8/23/2016
Eye Test May Detect Parkinson’s Before Symptoms Appear, University College London Study     8/19/2016
New Platform Hopes To Speed Diagnosis Of Parkinson's Disease And Breast Cancer, Oxford Impedance Diagnostics Reveals     8/1/2016
Cancer Drug Could Help Parkinson's, Dementia Patients, Georgetown University Study     7/14/2016
Detecting Parkinson’s Through A Urine Test, University of Alabama at Birmingham Study     7/8/2016
Blocking Key Enzyme Halts Parkinson's Disease Symptoms In Mice, Johns Hopkins University Study     6/29/2016
Pesticide-Linked Parkinson's Disease May Be Preventable, UCLA Scientists Reveal     6/16/2016
New Approaches To Early Identification Of Parkinson’s Disease     5/31/2016
Electronic Device Detects Molecules Linked To Cancer, Alzheimer's And Parkinson's, National Nanotechnology Laboratory Study     5/20/2016
Granddaughter Of Parkinson's Patient Invents "Smart" Walking Stick To Help Thousands Of Suffers, University of the West of England Study     5/18/2016
This Tremor Tracking Wearable Lets Parkinson's And ET Patients Take Charge     5/17/2016
Transplanted Nerve Cells Survive A Quarter Of A Century In A Parkinson’s Disease Patient, Lund University Study     5/4/2016

Press Releases
Newron Pharma (NWRN) Release: FDA Approves Xadago (Safinamide) For Parkinson's Disease (PD) Patients     3/22/2017
Inhibikase Therapeutics Awarded $433,000 From Inhibikase Therapeutics To Advance Development Of Kinase Inhibitor Treatment For Parkinson's Disease     3/9/2017
Renown Pharma Announces Successful Results Of Apomorphine Sub-Lingual Spray Pharmacokinetic Study To Treat "OFF" Episodes In Parkinson's Patients     3/7/2017
NeuroDerm (NDRM) Achieves Primary Endpoint In ND0612H Phase II Trial For Advanced Parkinson’s Disease; Seeks Broader EU Label Based On Indigo Trial Following EMA Meeting     3/1/2017
Adamas Pharma (ADMS) Presents Additional Open-Label, Long-Term Safety And Efficacy Data On ADS-5102 At The First Pan American Parkinson’s Disease And Movement Disorders Congress     2/28/2017
Okayama University Research: Potential Cause Of Lafora Disease Revealed     2/27/2017
Sanofi (SNY) Initiates Phase II Clinical Trial To Evaluate Therapy For Genetic Form Of Parkinson’s Disease     2/14/2017
Neurocrine Biosciences (NBIX) Nabs North American Rights to Bial's ONGENTYS     2/10/2017
Jazz Pharma (JAZZ) Announces First Patient Enrolled In Phase II Clinical Study Evaluating JZP-110 For Excessive Sleepiness In Parkinson's Disease     2/9/2017
Kainos Medicines Announces Initiation Of Phase 1 Clinical Study Of KM-819 In The Treatment Of Parkinson's Disease     1/27/2017
Biotech Support Group Release: Research Article Cites HemogloBind In Parkinson's Disease Study     1/26/2017
Selonterra Release: Biotech Publishes Novel Proprietary Mechanism for APOE4 In Alzheimer’s Disease     1/17/2017
Allergan (AGN) Enters Parkinson's Disease Through Option Arrangement With Lysosomal Therapeutics For Its Potential First-In-Class Breakthrough Compounds     1/9/2017
Adamas Pharma (ADMS) Announces U.S. FDA Acceptance Of ADS-5102 New Drug Application For The Treatment Of Levodopa-Induced Dyskinesia In Patients With Parkinson's Disease     1/6/2017
MC10 And UCB Group (UCBJF.PK) Complete Landmark Pharmaceutical / Technology Collaboration Evaluating Patient Monitoring In Parkinson’s     1/5/2017